Healthcare - Biotechnology - NASDAQ - US
$ 1.1
0 %
$ 307 M
Market Cap
-1.39
P/E
Price Target
Average
377.27%
Revenue Forecast
Estimate
55.75%
EBIT
Estimate
96.42%
Net Income
Estimate
9.54%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Lyell Immunopharma, Inc.
Wall Street analysts predict an average 1-year price target for LYEL of $5.25 , with forecasts ranging from a low of $1 to a high of $12 .
LYEL Lowest Price Target
Wall Street Target
1 USD
-9.09%
LYEL Average Price Target
Wall Street Target
5.25 USD
377.27%
LYEL Highest Price Target
Wall Street Target
12 USD
990.91%
REVENUE FORECAST
Revenue Forecast Chart LYEL
EBIT FORECAST
EBIT Forecast Chart LYEL
NET INCOME FORECAST
Net Income Chart LYEL